Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...

FRANKFURT: European shares closed slightly lower on Thursday after US President Donald Trump threatened to impose tariffs on ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

HealthDay News — Higher intake of butter is associated with increased mortality, according to a study published online March 6 in JAMA Internal Medicine to coincide with the American Heart Association ...

Stan Wong, portfolio manager at Scotia Wealth Management, discusses his past stock picks and how they're doing in the market ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Bearish flow noted in Novo Nordisk (NVO) with 7,917 puts trading, or 1.2x expected. Most active are 3/14 weekly 76 puts and Sep-25 110 puts, ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...

The pan-European Stoxx 600 edged down 0.2 per cent. Spirit-makers Pernod Ricard and Campari fell 4 per cent and 4.3 percent ...

European stocks dipped in volatile trading, with beverage makers sliding after US President Donald Trump threatened to put a ...

European shares experienced gains driven mainly by healthcare stocks, despite fears of an escalating U.S.-EU trade war. The ...